JMPWA
ATOS icon

JP Morgan Private Wealth Advisors’s Atossa Therapeutics ATOS Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,678
Closed -$31K – 1922
2022
Q1 		$31K Buy
1,678
+745
+80% +$15.1K ﹤0.01% 1965
2021
Q4 		$22K Buy
933
+200
+27% +$7.32K ﹤0.01% 1965
2021
Q3 		$36K Buy
+733
New +$42.6K ﹤0.01% 1921

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ATOS Position: Q2 2022 in Review

JP Morgan Private Wealth Advisors sold out of Atossa Therapeutics (ATOS) in Q2 2022, closing a stake of 1,678 shares — an estimated $31K sold.

JP Morgan Private Wealth Advisors first reported a position in ATOS in Q3 2021 and held it in 3 quarters. The position peaked at $36K in Q3 2021. 73 funds tracked by Wall St. Rank hold ATOS as of Q2 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Atossa Therapeutics position as of Q2 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 1,678 Atossa Therapeutics shares in Q2 2022, an estimated $31K.
  • JP Morgan Private Wealth Advisors first reported a position in Atossa Therapeutics in Q3 2021 and held it in 3 quarters.
  • JP Morgan Private Wealth Advisors's Atossa Therapeutics position peaked at $36K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.